According to Reuters, Bayer AG thinks it can become the biggest seller of prescription drugs in China this year, bypassing AstraZeneca, which is currently the top dog. Arthur J. Higgins, the head of Bayer Healthcare, said that revenues in China are growing at more than 40% annually. In 2008, they will top $500 million for the Germany-based pharma giant. More details...

Stock Symbols: (FSE: BAYA) (NYSE: AZN)